openPR Logo
Press release

Clinical Research in Ecuador - Diversity in Hispanic Community Involvement

05-23-2017 09:10 AM CET | Health & Medicine

Press release from: FOMAT Medical Research

Why is diversity important?

FDA Action Plan

In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including sex, age, race, and ethnicity.

Section 907 of the FDA Safety and Innovation Act of 2012 also includes recommendations for improving the completeness and quality of analyses of data on demographic subgroups.

In other words, most scientist, physicians and researchers are aware on how some treatments and medicines usually work differently on the demographic spectrum, some of them even harming a group while benefiting another. New research should include data from all the spectrum to ensure that particular medicine or treatment would word properly.

Number of clinical trials per country

According to the webpage in Latin America there are over 16 thousands studies in Latin America. Most of them conducted in Brazil, Mexico, Colombia and Argentina. Clinical Research in Ecuador is far from being saturated.

Clinical Research in Ecuador
Latin America is one of the unexploided regions for Clinical Trials. The region only has about 6% of the total Active Studies in the world and about 11% of total studies according to the website Clinical Research in Ecuador has less than 1% of total studies with over 88% of the times exceeding the enrollment goal

Clinical Research in Ecuador offers Access to a diverse population

One of the FDA’s goals is to create consciousness and make professional researchers aware about certain populations which may be more at risk for certain diseases—such as diabetes and heart disease—than others. It is important for researchers to include patients who are more likely to be treated for a condition that is common in those populations and recruit them in a trial.

Beside, data gathered over the years have shown that there can be important differences in how people from diverse groups respond to different medical treatments. Researchers should test these products in all groups and ensure they are safe and effective in everyone who will use them.

Information on those differences can then be included in the product labeling to help doctors and patients make treatment decisions.

Meeting these standards could be difficult in most regions. Nevertheless, Latin America offers a vast diversity for a rapid recruitment, most countries are multicultural and had become a great location to develop a broad-spectrum research.

As you can see, key countries in Latin America are highly diverse. For example, conducting Clinical Research in Ecuador will make it easier and faster to complete a recruitment process for a study while collecting diverse data than any other region.


Hispanics community is another one of the groups that have been forgotten by the clinical researchers. For many different reasons including the inexperience from both sides; researchers and patients. Efforts should be re-directed to encourage the inclusion of this community in order to provide better healthcare, medicine and treatments for them.

In the U.S. many institutes and colleges are aware of this situation and are already creating plans and educating patients and doctors to manage this issue.

By the other hand, conducting Clinical Research in Ecuador, an unexplored region for most pharmaceutical companies, means diversity of data, shorter recruitment times and important savings in money if you know how to manage these studies around the region. It’s highly recommended to contact experienced partners to help you move through the region effectively.

And also it is important to keep in mind that pharmaceutical markets in the Latin American region and in countries like this one, are far from being saturated.

To summarize, Ecuador is also an important region to develop clinical research. Its many advantages provides opportunities to small, mid-size or even big pharmaceuticals and CROs to provide the world with new and better treatments.

FOMAT Medical Research is pioneering Clinical Research in Ecuador, Colombia Peru and LatinAmerica. We are directing the Clinical Research Departments for several of the largest hospitals throughout the Americas. In Latin America, FOMAT is acknowledged as a Site Management Organization (SMO) with local Contract Research Organization (CRO) capabilities.

Diversifying Clinical Research is a top priority at FOMAT, which is why collecting data from Hispanic Sites is essential. Data is gathered through our numerous clinical sites, located in Ecuador, the United States, Colombia and Peru.

300th South Street A Suite 201 Oxnard, CA

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Research in Ecuador - Diversity in Hispanic Community Involvement here

News-ID: 546480 • Views: 232

More Releases from FOMAT Medical Research

Top 4 Benefits of Site Management Organization
Site management organizations are the organization that specializes in managing clinical research sites and offering clinical trial related services to pharmaceutical businesses, biotechnology companies among many others. Over the years, site management organizations have made an enormous contribution in overcoming several clinical hurdles throughout the conduct of the studies and thus reassuring the escalation of the market. Besides, you can find a plethora of site management organizations that have a

More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical